Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 280-285, March 2010

Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions

  • Hans Paul van der Laan

      Affiliations

    • Department of Radiation Oncology, University Medical Center Groningen/University of Groningen, Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands.
  • ,
  • Coen W. Hurkmans

      Affiliations

    • Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands
  • ,
  • Abraham Kuten

      Affiliations

    • Division of Oncology, Rambam Health Care Campus, Faculty of Medicine, Technion, Haifa, Israel
  • ,
  • Helen A. Westenberg

      Affiliations

    • Institute for Radiation Oncology Arnhem, Arnhem, The Netherlands
  • ,
  • On behalf of the EORTC-ROG Breast Working Party

Received 21 September 2009; received in revised form 9 December 2009; accepted 29 December 2009. published online 01 February 2010.

Abstract 

Purpose

To evaluate the current technological clinical practice of radiation therapy of the breast in institutions participating in the EORTC-Radiation Oncology Group (EORTC-ROG).

Materials and methods

A survey was conducted between August 2008 and January 2009 on behalf of the Breast Working Party within the EORTC-ROG. The questionnaire comprised 32 questions on 4 main topics: fractionation schedules, treatment planning methods, volume definitions and position verification procedures.

Results

Sixty-eight institutions out of 16 countries responded (a response rate of 47%). The standard fraction dose was generally 2Gy for both breast and boost treatment, although a 2.67Gy boost fraction dose is routinely given in British institutions. The main boost modality was electrons in 55%, photons in 47% and brachytherapy in 3% of the institutions (equal use of photon and electron irradiation in 5% of the institutions). All institutions used CT-based treatment planning. Wide variations are seen in the definition of the breast and boost target volumes, with margins around the resection cavity, ranging from 0 to 30mm. Inverse planned IMRT is available in 27% and breath-hold techniques in 19% of the institutions. The number of patients treated with IMRT and breath-hold varied per institution. Electronic portal imaging for patient set-up is used by 92% of the institutions.

Conclusions

This survey provides insight in the current practice of radiation technology used in the treatment of breast cancer among institutions participating in EORTC-ROG clinical trials.

Keywords: Breast radiotherapy, Clinical practice, Survey, Radiotherapy technique, EORTC

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(10)00009-5

doi:10.1016/j.radonc.2009.12.032

Radiotherapy & Oncology
Volume 94, Issue 3 , Pages 280-285, March 2010